What does this research mean for the field?

The putative lipid transporter gene arvA is essential for Aspergillus fumigatus in vitro morphogenesis and azole susceptibility, yet its loss does not attenuate in vivo pathogenicity due to complementation by the host pulmonary environment. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

This research investigates the role of the gene arvA in Aspergillus fumigatus morphogenesis, drug susceptibility, and pathogenicity.

May 17, 2026mSphereOpen Access

Insights into Aspergillus fumigatus morphogenesis and pathogenesis through the putative lipid transporter ArvA

View Full Paper

Ask AI

Bookmark

Authors

CGCecilia Gutierrez-Perez JJJane T. Jones CPCharles T. S. Puerner

Discussion

Member takes

Overview

Randomized trial reveals the role of ArvA in Aspergillus fumigatus morphology and drug susceptibility, highlighting implications for antifungal treatment strategies.

Key Points

This research investigates the role of the gene arvA in Aspergillus fumigatus morphogenesis, drug susceptibility, and pathogenicity.
Utilized murine models of invasive pulmonary aspergillosis
Analyzed the impact of arvA gene on fungal morphology and drug response
Assessed growth in presence of calf lung surfactant
Loss of arvA leads to hyper-swollen conidia and stunted, polarity-deficient hyphae.
Despite morphological defects, ∆arvA retains full pathogenicity and virulence in murine models.
Calf lung surfactant partially complements growth of ∆arvA, normalizing some defects.

Cite This Study

Gutierrez-Perez et al. (2026) studied this question.

synapsesocial.com/papers/6a095af37880e6d24efe0c9e https://doi.org/10.1128/msphere.00853-25

View Full Paper

Ask AI

Bookmark

May 17, 2026mSphereOpen Access

Insights into Aspergillus fumigatus morphogenesis and pathogenesis through the putative lipid transporter ArvA

View Full Paper

Ask AI

Bookmark

Authors

CGCecilia Gutierrez-Perez JJJane T. Jones CPCharles T. S. Puerner

Discussion

Member takes

Overview

Randomized trial reveals the role of ArvA in Aspergillus fumigatus morphology and drug susceptibility, highlighting implications for antifungal treatment strategies.

Key Points

This research investigates the role of the gene arvA in Aspergillus fumigatus morphogenesis, drug susceptibility, and pathogenicity.
Utilized murine models of invasive pulmonary aspergillosis
Analyzed the impact of arvA gene on fungal morphology and drug response
Assessed growth in presence of calf lung surfactant
Loss of arvA leads to hyper-swollen conidia and stunted, polarity-deficient hyphae.
Despite morphological defects, ∆arvA retains full pathogenicity and virulence in murine models.
Calf lung surfactant partially complements growth of ∆arvA, normalizing some defects.

Cite This Study

Gutierrez-Perez et al. (2026) studied this question.

synapsesocial.com/papers/6a095af37880e6d24efe0c9e https://doi.org/10.1128/msphere.00853-25

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark